- Home
- Companies
- north america
- major depressive disorder
Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Manufacturing, Other
- Automobile & Ground Transport
- Defense
- Electronics and Computers
- Aerospace & Air Transport
- Waste and Recycling
- Oil, Gas & Refineries
- Monitoring and Testing
- Environmental
- Health and Safety
- Air and Climate
- University / Academia / Research
- Government
- Food and Beverage
Major Depressive Disorder Suppliers In North America
8 companies found
based inBurlington, MASSACHUSETTS (USA)
BrainsWay focuses on developing cutting-edge medical devices that help advance the level of treatment offered to patients. To do so, BrainsWay’s advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS) is expanding the ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist, apoptosis inducer, and common disease inducer in experimental animals, constructing models of muscle atrophy, hypertension, and depression. Dexamethasone can inhibit the production ...
based inNew York, NEW YORK (USA)
We develop, validate, and commercialize software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are ...
Click is researching multiple cognitive exercises for the treatment of ...
based inCoral Gables, FLORIDA (USA)
We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...
REL-1017 is a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker in phase 3 clinical trials for the treatment of Major Depressive Disorder (MDD). REL-1017 works with a MOA markedly ...
based inNew Haven, CONNECTICUT (USA)
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge ...
It is being investigated for at-home use for the acute treatment of agitation in bipolar and schizophrenia patients, for agitation in Alzheimer’s disease, and as an adjunctive treatment for major depressive ...
based inInnsbruck, AUSTRIA
IONICON is the world's leading manufacturer of ultra-sensitive real-time trace gas analyzers based on the unique Proton Transfer Reaction – Mass Spectrometry (PTR-MS) and proprietary SRI-MS technology. IONICON also produces industrial process ...
based inMalvern, PENNSYLVANIA (USA)
NeuroStar is the market leader in Transcranial Magnetic Stimulation technology for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) focused on developing non-invasive therapies for ...
based inPrinceton, NEW JERSEY (USA)
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka researches, develops, manufactures, and markets innovative products, with a focus ...
After it is swallowed, ABILIFY MYCITE® (aripiprazole tablets with sensor) sends a tiny signal to a wearable Bluetooth®* patch that connects with your smartphone, allowing you to see your daily data all in one ...